USD 71.47
(-1.09%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 9.15 Billion USD | 0.18% |
2023 | 9.13 Billion USD | 0.75% |
2022 | 9.07 Billion USD | 1.7% |
2021 | 8.91 Billion USD | 23.96% |
2020 | 7.19 Billion USD | 8.84% |
2019 | 6.61 Billion USD | -8.57% |
2018 | 7.23 Billion USD | -9.38% |
2017 | 7.97 Billion USD | 9.06% |
2016 | 7.31 Billion USD | -4.6% |
2015 | 7.67 Billion USD | -8.85% |
2014 | 8.41 Billion USD | -6.51% |
2013 | 9 Billion USD | -14.09% |
2012 | 10.47 Billion USD | 74.36% |
2011 | 6 Billion USD | 6.81% |
2010 | 5.62 Billion USD | -1.12% |
2009 | 5.68 Billion USD | -30.05% |
2008 | 8.13 Billion USD | 662.85% |
2007 | 1.06 Billion USD | 24.54% |
2006 | 856.2 Million USD | 205.96% |
2005 | 279.83 Million USD | 32.15% |
2004 | 211.75 Million USD | 12.27% |
2003 | 188.6 Million USD | 2.35% |
2002 | 184.27 Million USD | -5.56% |
2001 | 195.11 Million USD | -11.17% |
2000 | 219.65 Million USD | 24.95% |
1999 | 175.8 Million USD | 1.85% |
1998 | 172.6 Million USD | 19.28% |
1997 | 144.7 Million USD | 17.55% |
1996 | 123.1 Million USD | 263.13% |
1995 | 33.9 Million USD | 18.95% |
1994 | 28.5 Million USD | 28.38% |
1993 | 22.2 Million USD | -2.2% |
1992 | 22.7 Million USD | 14.65% |
1991 | 19.8 Million USD | -2.46% |
1990 | 20.3 Million USD | 275.93% |
1989 | 5.4 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 8.89 Billion USD | 2.02% |
2024 Q4 | 9.15 Billion USD | 2.99% |
2024 Q2 | 8.71 Billion USD | 2.89% |
2024 Q1 | 8.46 Billion USD | -7.33% |
2023 Q3 | 9.33 Billion USD | -1.17% |
2023 Q2 | 9.44 Billion USD | 1.71% |
2023 Q1 | 9.29 Billion USD | 2.42% |
2023 FY | 9.13 Billion USD | 0.75% |
2023 Q4 | 9.13 Billion USD | -2.13% |
2022 FY | 9.07 Billion USD | 1.7% |
2022 Q3 | 9.35 Billion USD | -1.65% |
2022 Q4 | 9.07 Billion USD | -3.06% |
2022 Q2 | 9.51 Billion USD | 2.47% |
2022 Q1 | 9.28 Billion USD | 4.09% |
2021 Q1 | 7.55 Billion USD | 4.93% |
2021 Q2 | 8.04 Billion USD | 6.53% |
2021 Q4 | 8.91 Billion USD | 3.83% |
2021 Q3 | 8.59 Billion USD | 6.8% |
2021 FY | 8.91 Billion USD | 23.96% |
2020 Q1 | 6.31 Billion USD | -4.53% |
2020 Q2 | 6.82 Billion USD | 8.08% |
2020 Q3 | 6.8 Billion USD | -0.27% |
2020 Q4 | 7.19 Billion USD | 5.77% |
2020 FY | 7.19 Billion USD | 8.84% |
2019 Q4 | 6.61 Billion USD | 1.36% |
2019 FY | 6.61 Billion USD | -8.57% |
2019 Q2 | 6.52 Billion USD | -5.86% |
2019 Q1 | 6.93 Billion USD | -4.14% |
2019 Q3 | 6.52 Billion USD | -0.04% |
2018 FY | 7.23 Billion USD | -9.38% |
2018 Q2 | 7.23 Billion USD | -10.11% |
2018 Q4 | 7.23 Billion USD | 1.97% |
2018 Q3 | 7.09 Billion USD | -1.98% |
2018 Q1 | 8.04 Billion USD | 0.86% |
2017 Q4 | 7.97 Billion USD | -1.7% |
2017 FY | 7.97 Billion USD | 9.06% |
2017 Q1 | 7.33 Billion USD | 0.28% |
2017 Q2 | 8.7 Billion USD | 18.65% |
2017 Q3 | 8.11 Billion USD | -6.76% |
2016 Q4 | 7.31 Billion USD | 0.14% |
2016 Q3 | 7.3 Billion USD | 0.28% |
2016 Q2 | 7.28 Billion USD | -5.12% |
2016 Q1 | 7.67 Billion USD | 0.12% |
2016 FY | 7.31 Billion USD | -4.6% |
2015 Q4 | 7.67 Billion USD | -5.66% |
2015 FY | 7.67 Billion USD | -8.85% |
2015 Q2 | 8.03 Billion USD | -0.57% |
2015 Q3 | 8.13 Billion USD | 1.23% |
2015 Q1 | 8.07 Billion USD | -4.0% |
2014 Q1 | 8.48 Billion USD | -5.74% |
2014 Q2 | 8.36 Billion USD | -1.44% |
2014 Q3 | 8.41 Billion USD | 0.59% |
2014 FY | 8.41 Billion USD | -6.51% |
2014 Q4 | 8.41 Billion USD | 0.03% |
2013 Q3 | 10.33 Billion USD | 0.23% |
2013 Q1 | 10.46 Billion USD | -0.08% |
2013 Q2 | 10.3 Billion USD | -1.52% |
2013 Q4 | 9 Billion USD | -12.89% |
2013 FY | 9 Billion USD | -14.09% |
2012 Q4 | 10.47 Billion USD | 73.84% |
2012 FY | 10.47 Billion USD | 74.36% |
2012 Q3 | 6.02 Billion USD | -0.35% |
2012 Q2 | 6.04 Billion USD | 0.04% |
2012 Q1 | 6.04 Billion USD | 0.62% |
2011 Q2 | 5.83 Billion USD | 3.01% |
2011 Q1 | 5.66 Billion USD | 0.71% |
2011 Q3 | 5.93 Billion USD | 1.73% |
2011 FY | 6 Billion USD | 6.81% |
2011 Q4 | 6 Billion USD | 1.21% |
2010 Q1 | 5.68 Billion USD | -0.13% |
2010 Q2 | 5.73 Billion USD | 1.01% |
2010 Q3 | 5.73 Billion USD | -0.16% |
2010 Q4 | 5.62 Billion USD | -1.83% |
2010 FY | 5.62 Billion USD | -1.12% |
2009 Q4 | 5.68 Billion USD | -0.5% |
2009 FY | 5.68 Billion USD | -30.05% |
2009 Q2 | 5.78 Billion USD | -28.95% |
2009 Q1 | 8.13 Billion USD | 0.06% |
2009 Q3 | 5.71 Billion USD | -1.13% |
2008 Q4 | 8.13 Billion USD | 4.11% |
2008 FY | 8.13 Billion USD | 662.85% |
2008 Q3 | 7.81 Billion USD | 0.3% |
2008 Q1 | 7.89 Billion USD | 640.72% |
2008 Q2 | 7.79 Billion USD | -1.37% |
2007 Q2 | 871.5 Million USD | 0.4% |
2007 Q3 | 933.9 Million USD | 7.16% |
2007 FY | 1.06 Billion USD | 24.54% |
2007 Q4 | 1.06 Billion USD | 14.18% |
2007 Q1 | 867.99 Million USD | 1.38% |
2006 Q2 | 332.98 Million USD | 13.18% |
2006 Q3 | 401.15 Million USD | 20.47% |
2006 FY | 856.2 Million USD | 205.96% |
2006 Q4 | 856.2 Million USD | 113.44% |
2006 Q1 | 294.21 Million USD | 5.14% |
2005 Q3 | 259.2 Million USD | 7.48% |
2005 FY | 279.83 Million USD | 32.15% |
2005 Q4 | 279.83 Million USD | 7.96% |
2005 Q1 | 215.69 Million USD | 1.86% |
2005 Q2 | 241.15 Million USD | 11.8% |
2004 Q1 | 192.44 Million USD | 2.04% |
2004 FY | 211.75 Million USD | 12.27% |
2004 Q4 | 211.75 Million USD | 4.37% |
2004 Q3 | 202.88 Million USD | 3.1% |
2004 Q2 | 196.78 Million USD | 2.25% |
2003 Q3 | 183.24 Million USD | 0.49% |
2003 Q2 | 182.35 Million USD | 1.66% |
2003 Q1 | 179.38 Million USD | -2.65% |
2003 Q4 | 188.6 Million USD | 2.92% |
2003 FY | 188.6 Million USD | 2.35% |
2002 Q1 | 206.88 Million USD | 6.03% |
2002 Q4 | 184.27 Million USD | -13.08% |
2002 Q3 | 212.01 Million USD | 0.08% |
2002 FY | 184.27 Million USD | -5.56% |
2002 Q2 | 211.84 Million USD | 2.4% |
2001 Q2 | 202.19 Million USD | -3.87% |
2001 FY | 195.11 Million USD | -11.17% |
2001 Q4 | 195.11 Million USD | 1.37% |
2001 Q3 | 192.47 Million USD | -4.81% |
2001 Q1 | 210.33 Million USD | -4.24% |
2000 Q2 | 172 Million USD | -1.43% |
2000 Q4 | 219.65 Million USD | 28.75% |
2000 FY | 219.65 Million USD | 24.95% |
2000 Q1 | 174.5 Million USD | -0.74% |
2000 Q3 | 170.6 Million USD | -0.81% |
1999 Q3 | 181.2 Million USD | 6.71% |
1999 FY | 175.8 Million USD | 1.85% |
1999 Q4 | 175.8 Million USD | -2.98% |
1999 Q2 | 169.8 Million USD | -4.39% |
1999 Q1 | 177.6 Million USD | 2.9% |
1998 Q4 | 172.6 Million USD | 2.62% |
1998 Q3 | 168.2 Million USD | 5.79% |
1998 Q1 | 151.3 Million USD | 4.56% |
1998 FY | 172.6 Million USD | 19.28% |
1998 Q2 | 159 Million USD | 5.09% |
1997 Q3 | 141 Million USD | 3.98% |
1997 Q4 | 144.7 Million USD | 2.62% |
1997 FY | 144.7 Million USD | 17.55% |
1997 Q1 | 131.1 Million USD | 6.5% |
1997 Q2 | 135.6 Million USD | 3.43% |
1996 FY | 123.1 Million USD | 263.13% |
1996 Q4 | 123.1 Million USD | 21.76% |
1996 Q3 | 101.1 Million USD | 10.61% |
1996 Q2 | 91.4 Million USD | 147.03% |
1996 Q1 | 37 Million USD | 9.14% |
1995 Q3 | 32.8 Million USD | 7.89% |
1995 FY | 33.9 Million USD | 18.95% |
1995 Q1 | 29.3 Million USD | 2.81% |
1995 Q4 | 33.9 Million USD | 3.35% |
1995 Q2 | 30.4 Million USD | 3.75% |
1994 Q3 | 27 Million USD | 10.2% |
1994 FY | 28.5 Million USD | 28.38% |
1994 Q2 | 24.5 Million USD | 7.46% |
1994 Q1 | 22.8 Million USD | 2.7% |
1994 Q4 | 28.5 Million USD | 5.56% |
1993 FY | 22.2 Million USD | -2.2% |
1993 Q2 | 21.7 Million USD | 0.0% |
1993 Q3 | 22.1 Million USD | 1.84% |
1993 Q4 | 22.2 Million USD | 0.45% |
1992 Q1 | 19.9 Million USD | 0.51% |
1992 Q2 | 21.7 Million USD | 9.05% |
1992 FY | 22.7 Million USD | 14.65% |
1992 Q4 | 22.7 Million USD | -2.16% |
1992 Q3 | 23.2 Million USD | 6.91% |
1991 FY | 19.8 Million USD | -2.46% |
1991 Q4 | 19.8 Million USD | 0.0% |
1990 Q4 | 20.3 Million USD | 0.0% |
1990 Q2 | 16.5 Million USD | 0.0% |
1990 FY | 20.3 Million USD | 275.93% |
1989 Q4 | 5.4 Million USD | 0.0% |
1989 FY | 5.4 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | -4976.26% |
AngioDynamics, Inc. | 317.67 Million USD | -2782.227% |
AtriCure, Inc. | 613.93 Million USD | -1391.37% |
Avinger, Inc. | 13.77 Million USD | -66392.375% |
Azenta, Inc. | 2.88 Billion USD | -217.287% |
BioLife Solutions, Inc. | 412.71 Million USD | -2118.485% |
The Cooper Companies, Inc. | 11.65 Billion USD | 21.468% |
Daxor Corporation | 34.86 Million USD | -26158.174% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | -31561.941% |
Femasys Inc. | 27.75 Million USD | -32887.67% |
GlucoTrack, Inc. | 4.9 Million USD | -186566.667% |
Harvard Bioscience, Inc. | 137.36 Million USD | -6565.405% |
ICU Medical, Inc. | 4.37 Billion USD | -109.116% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 40.705% |
KORU Medical Systems, Inc. | 28.46 Million USD | -32070.37% |
LeMaitre Vascular, Inc. | 346.77 Million USD | -2540.306% |
Innovative Eyewear, Inc. | 6.21 Million USD | -147131.877% |
Innovative Eyewear, Inc. | 6.21 Million USD | -147131.877% |
Masimo Corporation | 3.04 Billion USD | -201.036% |
Microbot Medical Inc. | 8.32 Million USD | -109855.566% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -5225.879% |
Merit Medical Systems, Inc. | 2.32 Billion USD | -293.765% |
Nephros, Inc. | 11.86 Million USD | -77094.166% |
NovoCure Limited | 1.14 Billion USD | -698.863% |
NEXGEL, Inc. | 9.95 Million USD | -91873.882% |
NEXGEL, Inc. | 9.95 Million USD | -91873.882% |
Singular Genomics Systems, Inc. | 265.46 Million USD | -3349.016% |
OraSure Technologies, Inc. | 482.84 Million USD | -1796.261% |
Pro-Dex, Inc. | 54.21 Million USD | -16789.873% |
Pulse Biosciences, Inc. | 60.8 Million USD | -14958.22% |
Predictive Oncology Inc. | 14.41 Million USD | -63407.261% |
Precision Optics Corporation, Inc. | 16.91 Million USD | -54037.235% |
QuidelOrtho Corporation | 8.56 Billion USD | -6.924% |
Repligen Corporation | 2.82 Billion USD | -224.174% |
Sanara MedTech Inc. | 73.87 Million USD | -12294.555% |
STAAR Surgical Company | 488.69 Million USD | -1773.573% |
Sharps Technology, Inc. | 11.78 Million USD | -77563.855% |
Utah Medical Products, Inc. | 135.45 Million USD | -6659.291% |
DENTSPLY SIRONA Inc. | 7.37 Billion USD | -24.233% |
Jin Medical International Ltd. | 32.9 Million USD | -27726.869% |